Innovaderm Research
Innovaderm Research is a leading dermatology-focused clinical research organization (CRO) established in 2000. It specializes in managing early to late phase clinical trials in dermatology and rheumatology, partnering with biotechnology and pharmaceutical companies. With a mission to drive innovative research and develop new therapies, Innovaderm operates as one of North America's largest Clinical Research Units (CRU), offering state-of-the-art facilities, experienced dermatologists, and comprehensive services to advance medical knowledge and improve patient outcomes.
Industries
Nr. of Employees
medium (51-250)
Innovaderm Research
Services
End-to-end clinical development services for biotechnology and pharmaceutical sponsors including study design, site management, monitoring, data management, and biometrics support for early to late phase trials.
On-site clinical research unit providing participant screening, medical follow-up, study visits, an on-site pharmacy, and specialized equipment for dermatology studies.
Modular biostatistics and clinical data management services offered as a dedicated unit, including protocol design support, statistical analysis plans, statistical programming, and reporting.
Design and operationalization of decentralized or hybrid clinical trials using eCOA, TeleVisits, and other digital workflows to enable remote assessments and improve patient access.
Operational support and accredited expertise with electronic data capture platforms and clinical data management processes for regulated clinical trials.
End-to-end clinical development services for biotechnology and pharmaceutical sponsors including study design, site management, monitoring, data management, and biometrics support for early to late phase trials.
On-site clinical research unit providing participant screening, medical follow-up, study visits, an on-site pharmacy, and specialized equipment for dermatology studies.
Modular biostatistics and clinical data management services offered as a dedicated unit, including protocol design support, statistical analysis plans, statistical programming, and reporting.
Design and operationalization of decentralized or hybrid clinical trials using eCOA, TeleVisits, and other digital workflows to enable remote assessments and improve patient access.
Operational support and accredited expertise with electronic data capture platforms and clinical data management processes for regulated clinical trials.
Expertise Areas
- Clinical trial management
- Dermatology clinical research
- Biometrics and biostatistics
- Decentralized and hybrid clinical trials
Key Technologies
- Electronic data capture (EDC)
- Electronic clinical outcome assessments (eCOA)
- TeleVisits / telemedicine for trials
- Cloud-based decentralized trial platforms
News & Updates
Innovaderm will be in Washington, D.C. from November 14th to 19th to meet with professionals at the American College of Rheumatology (ACR) Congress, booth #2700.
Innovaderm hosted a free breakfast event on March 26 at the AAD Annual Meeting in Boston, focusing on skin barrier dysfunction and atopic dermatitis, with expert speakers Drs. Alan D. Irvine and Robert Bissonnette.
Innovaderm shares its involvement in the development process of Dermavant’s VTAMA® (tapinarof) cream, including all phases of clinical development and successful collaboration leading to FDA approval.
Innovaderm announced the appointment of Jeff Smith as the new CEO, with founder Dr. Robert Bissonnette becoming Executive Chairman, to support its leadership in dermatology and rheumatology research.
Innovaderm received the 2022 CRO Leadership Award in the Quality and Reliability categories, recognizing its excellence in clinical research services in dermatology.
Innovaderm will be in Washington, D.C. from November 14th to 19th to meet with professionals at the American College of Rheumatology (ACR) Congress, booth #2700.
Innovaderm hosted a free breakfast event on March 26 at the AAD Annual Meeting in Boston, focusing on skin barrier dysfunction and atopic dermatitis, with expert speakers Drs. Alan D. Irvine and Robert Bissonnette.
Innovaderm shares its involvement in the development process of Dermavant’s VTAMA® (tapinarof) cream, including all phases of clinical development and successful collaboration leading to FDA approval.
Innovaderm announced the appointment of Jeff Smith as the new CEO, with founder Dr. Robert Bissonnette becoming Executive Chairman, to support its leadership in dermatology and rheumatology research.
Innovaderm received the 2022 CRO Leadership Award in the Quality and Reliability categories, recognizing its excellence in clinical research services in dermatology.